On (b)(6) 2016, leica biosystems received information that one (1) case was not diagnosable.It was reported that the pathologist had stated that the tissue was of questionable quality prior to processing and it was unknown whether the circumstances involved in this complaint contributed to the recommendation for re-biopsy.It was also not known whether the recommended rebiopsy had been performed.Leica biosystems was advised by the complainant that the reported sub-optimal tissue processing may have been caused by human error.
|